| Jun 20 |
Mustang Bio announces $2.5M registered direct offering
|
| Jun 20 |
Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
| Jun 18 |
Mustang Bio stock soars 45% after closing 477% higher in prior session
|
| Jun 18 |
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
|
| Jun 18 |
Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
|
| Jun 18 |
Palantir, Mustang Bio, DraftKings, Micron, Tesla: Why These 5 Stocks Are On Investors' Radars Today
|
| Jun 17 |
Mustang Bio stock rockets 580% on blood cancer drug study
|
| Jun 17 |
Top Midday Gainers
|
| Jun 17 |
Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy
|
| May 31 |
Mustang Bio files for $40M mixed shelf offering
|
